2026 NPPES data Pharmacotherapy Pharmacist NPI 1447818745 PHARMD
Verify on CMS →

Lindsay Breland, PHARMD

Pharmacotherapy Pharmacist in Amarillo, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 5,925 in Pharmacotherapy Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
170
Medicare Part D claims · 38 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
49%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Lindsay Breland, PHARMD filed 170 Medicare Part D claims in 2023 as a Pharmacotherapy Pharmacist in Amarillo, Texas, prescribing 49% generic.

170
Part D claims, 2023
49%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Lindsay Breland, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

170 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Lindsay Breland, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 05/31/2019

NPI 1447818745

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

170 57% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in Texas

How Pharmacotherapy Pharmacist compares to other specialties among Texas providers

Texas providers
Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Pharmacotherapy Pharmacist - 0.1%Pharmacotherapy Pharmacist0.1%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pharmacotherapy Pharmacist. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Lindsay Breland, PHARMD appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARMD credentials at 1400 S COULTER ST STE 2400, Amarillo, TX, 79106, with a listed phone of (806) 414-9100. NPI 1447818745 was issued on 05/31/2019.

Medicare Part D records for calendar year 2023 show 170 prescription claims written by this provider, covering 38 Medicare beneficiaries and totaling roughly $69K in drug spend, split 42% brand-name and 49% generic by claim count.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1400 S COULTER ST STE 2400
Amarillo, TX 79106

Provider Details

NPI 1447818745
Specialty Pharmacotherapy Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 05/31/2019

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Lindsay Breland, PHARMD. To verify Lindsay Breland, PHARMD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Lindsay Breland, PHARMD - brand share 42.0%
Pharmacotherapy Pharmacist average

42% brand-name claims vs 49% generic, on 170 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

170
Total Claims
$69K
Total Drug Cost
38
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
337
Total Day Supply
9,925
Brand vs Generic
42% brand / 49% generic
Brand Drug Cost
$67K
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
67.4 years
Avg HCC Risk Score
2.01
Gender Split
55% female / 45% male
Age Distribution
<65: 12, 65-74: 16, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Lindsay Breland, PHARMD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trulicity
Dulaglutide
21
Warfarin Sodium
16
Ozempic
Semaglutide
13
Atorvastatin Calcium
11
Lantus Solostar
"Insulin Glargine
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How Lindsay Breland, PHARMD fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

Lindsay Breland, PHARMD's 170 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Breland.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pharmacotherapy Pharmacist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Lindsay Breland, PHARMD's specialty?
Lindsay Breland, PHARMD specializes in Pharmacotherapy Pharmacist and practices in Amarillo, Texas. Credentials: PHARMD.
How much does Lindsay Breland, PHARMD prescribe under Medicare Part D?
In 2023, Lindsay Breland, PHARMD wrote 170 Medicare Part D claims totaling $69K in drug costs for 38 beneficiaries.
Where is Lindsay Breland, PHARMD located?
Lindsay Breland, PHARMD is located at 1400 S COULTER ST STE 2400, Amarillo, TX, 79106. Phone: (806) 414-9100.
What is Lindsay Breland, PHARMD's NPI number?
Lindsay Breland, PHARMD's National Provider Identifier (NPI) is 1447818745, issued on 05/31/2019.
Does Lindsay Breland, PHARMD prescribe more brand-name or generic drugs?
Lindsay Breland, PHARMD's prescribing is 42% brand-name and 49% generic drugs by claim count, with $67K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does Lindsay Breland, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, Lindsay Breland, PHARMD's most frequently prescribed drugs include Trulicity, Warfarin Sodium, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lindsay Breland, PHARMD accept Medicare?
Lindsay Breland, PHARMD appears in CMS Medicare data with 170 Part D claims and 38 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lindsay Breland, PHARMD's credentials?
Lindsay Breland, PHARMD's NPI is 1447818745 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.